SG141418A1 - Method for the detection of gene transcripts in blood and uses thereof - Google Patents

Method for the detection of gene transcripts in blood and uses thereof

Info

Publication number
SG141418A1
SG141418A1 SG200719158-8A SG2007191588A SG141418A1 SG 141418 A1 SG141418 A1 SG 141418A1 SG 2007191588 A SG2007191588 A SG 2007191588A SG 141418 A1 SG141418 A1 SG 141418A1
Authority
SG
Singapore
Prior art keywords
disease
blood
detection
diagnosing
gene transcripts
Prior art date
Application number
SG200719158-8A
Other languages
English (en)
Inventor
Choong-Chin Liew
Original Assignee
Genenews Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/601,518 external-priority patent/US20070031841A1/en
Application filed by Genenews Inc filed Critical Genenews Inc
Publication of SG141418A1 publication Critical patent/SG141418A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SG200719158-8A 2003-06-20 2004-06-21 Method for the detection of gene transcripts in blood and uses thereof SG141418A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/601,518 US20070031841A1 (en) 2001-02-28 2003-06-20 Method for the detection of gene transcripts in blood and uses thereof
US10/809,675 US20050123938A1 (en) 1999-01-06 2004-03-25 Method for the detection of osteoarthritis related gene transcripts in blood

Publications (1)

Publication Number Publication Date
SG141418A1 true SG141418A1 (en) 2008-04-28

Family

ID=33544775

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200719158-8A SG141418A1 (en) 2003-06-20 2004-06-21 Method for the detection of gene transcripts in blood and uses thereof

Country Status (7)

Country Link
US (6) US20050123938A1 (de)
EP (1) EP1643893A4 (de)
JP (1) JP2007528704A (de)
AU (1) AU2004249318A1 (de)
CA (1) CA2530191A1 (de)
SG (1) SG141418A1 (de)
WO (1) WO2004112589A2 (de)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070105105A1 (en) * 2003-05-23 2007-05-10 Mount Sinai School Of Medicine Of New York University Surrogate cell gene expression signatures for evaluating the physical state of a subject
EP1668111A4 (de) * 2003-08-08 2008-07-02 Genenews Inc Osteoarthritis-biomarker und verwendungen davon
US20050095634A1 (en) * 2003-10-16 2005-05-05 Genomic Health Inc. qRT-PCR assay system for gene expression profiling
US20050208519A1 (en) * 2004-03-12 2005-09-22 Genenews Inc. Biomarkers for diagnosing schizophrenia and bipolar disorder
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
EP2520669A3 (de) * 2005-02-07 2013-02-27 GeneNews Inc. Biomarker für milde Arthrose und Verwendungen davon
EP2311983A1 (de) 2005-02-10 2011-04-20 Oncotherapy Science, Inc. Verfahren zur Behandlung von Blasenkrebs mit siRNA
US20100221186A1 (en) 2005-03-11 2010-09-02 Hueseyin Firat Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
CN102191320A (zh) 2005-05-02 2011-09-21 东丽株式会社 用于诊断食管癌的组合物及方法
ATE534751T1 (de) * 2005-05-30 2011-12-15 Takeda Pharmaceutical Verwendung von prkx zur diagnose und therapie von alzheimer krankheit
EP1930445B1 (de) * 2005-09-02 2010-03-31 Toray Industries, Inc. Kit und verfahren zum nachweis von urothelkarzinom
JP4870976B2 (ja) * 2005-11-10 2012-02-08 株式会社Ｄｎａチップ研究所 全血を用いた自己免疫疾患の検査方法
US20080075789A1 (en) * 2006-02-28 2008-03-27 The Regents Of The University Of California Genes differentially expressed in bipolar disorder and/or schizophrenia
US7943310B2 (en) * 2006-08-30 2011-05-17 Centocor Ortho Biotech Inc. Methods for assessing response to therapy in subjects having ulcerative colitis
US8158374B1 (en) 2006-09-05 2012-04-17 Ridge Diagnostics, Inc. Quantitative diagnostic methods using multiple parameters
US10546652B2 (en) * 2006-09-29 2020-01-28 Gearbox Llc Computational systems for biomedical data
US20080109484A1 (en) * 2006-09-29 2008-05-08 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080091730A1 (en) * 2006-09-29 2008-04-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082306A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082271A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US20080082584A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10503872B2 (en) * 2006-09-29 2019-12-10 Gearbox Llc Computational systems for biomedical data
US20080082364A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US20080082367A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Computational systems for biomedical data
US10068303B2 (en) 2006-09-29 2018-09-04 Gearbox Llc Computational systems for biomedical data
US20080082307A1 (en) * 2006-09-29 2008-04-03 Searete Llc Computational systems for biomedical data
US8122073B2 (en) 2006-09-29 2012-02-21 The Invention Science Fund I Computational systems for biomedical data
US20080082359A1 (en) * 2006-09-29 2008-04-03 Searete Llc, A Limited Liability Corporation Of State Of Delaware Computational systems for biomedical data
US10095836B2 (en) * 2006-09-29 2018-10-09 Gearbox Llc Computational systems for biomedical data
CN102850434B (zh) 2006-10-17 2016-04-13 肿瘤疗法科学股份有限公司 用于表达mphosph1或depdc1多肽的癌症的肽疫苗
US20100256001A1 (en) * 2007-04-03 2010-10-07 The Scripps Research Institute Blood biomarkers for mood disorders
US8187810B2 (en) * 2007-05-16 2012-05-29 Wellman Wai-Man Cheung Method for diagnosing overactive bladder
FR2929292A1 (fr) 2008-03-28 2009-10-02 Exonhit Therapeutics S A Sa Procede et methodes de diagnostic de la maladie d'alzheimer
CA2721313A1 (en) 2008-04-10 2009-10-15 Genenews Corporation Method and apparatus for determining a probability of colorectal cancer in a subject
CN102016072A (zh) * 2008-04-21 2011-04-13 诺瓦提斯研究基金会弗里德里克·米谢尔生物医学研究所 抗病毒疗法
WO2010012086A1 (en) * 2008-07-28 2010-02-04 Genenews Corporation Methods and compositions for determining severity of heart failure in a subject
EP2362904B1 (de) 2008-08-28 2016-11-16 Oncotherapy Science, Inc. Verfahren zum screenen von verbindungen zur verwendung bei der hemmung der depdc1 - znf224 bindung
JP2010057407A (ja) * 2008-09-03 2010-03-18 Srl Inc 双極性障害と統合失調症の判別方法
AU2009290811A1 (en) * 2008-09-12 2010-03-18 Universitatsklinikum Munster Means and methods for evaluating a therapy with a p38 map kinase inhibitor
CN102257157A (zh) * 2008-10-15 2011-11-23 里奇诊断学股份有限公司 人抑郁症的生物标记超映射
US20100105054A1 (en) * 2008-10-15 2010-04-29 Cincinnati Children's Hospital Medical Center Gene expression in duchenne muscular dystrophy
JP5767973B2 (ja) * 2008-11-18 2015-08-26 リッジ ダイアグノスティックス，インコーポレイテッド 大うつ病性障害のためのメタボリック症候群バイオマーカーおよびｈｐａ軸バイオマーカー
WO2010062960A2 (en) 2008-11-26 2010-06-03 Cedars-Sinai Medical Center METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE
US20100280760A1 (en) * 2009-04-01 2010-11-04 Ridge Diagnostics, Inc. Biomarkers for monitoring treatment of neuropsychiatric diseases
JP2012523009A (ja) * 2009-04-06 2012-09-27 リッジ ダイアグノスティックス，インコーポレイテッド 精神神経疾患の治療をモニタリングするためのバイオマーカー
US20120073585A1 (en) * 2009-04-08 2012-03-29 Cedars-Sinai Medical Center Methods of predicting complication and surgery in crohn's disease
KR100964193B1 (ko) * 2009-04-17 2010-06-16 씨비에스바이오사이언스 주식회사 간암 예후 마커
JP2012526828A (ja) * 2009-05-11 2012-11-01 バーグ バイオシステムズ，エルエルシー エピメタボリックシフター、多次元細胞内分子、または環境影響因子を使用する代謝性障害の治療方法
EP2757160A3 (de) * 2009-07-20 2014-07-30 Genentech, Inc. Genexpressionsmarker für Morbus Crohn
WO2011094308A2 (en) * 2010-01-26 2011-08-04 Ridge Diagnostics, Inc. Multiple biomarker panels to stratify disease severity and monitor treatment of depression
US20130143748A1 (en) * 2010-05-27 2013-06-06 Sekisui Medical Co., Ltd. Methods for detection of risk of obesity and risk of onset of diabetes
US20120095775A1 (en) * 2010-10-19 2012-04-19 International Business Machines Corporation Characterizing, tracking and optimizing population health based on integration of multi-disciplinary databases
US10318877B2 (en) 2010-10-19 2019-06-11 International Business Machines Corporation Cohort-based prediction of a future event
AU2011333780A1 (en) * 2010-11-24 2013-06-06 F. Hoffmann-La Roche Ag Methods for detecting low grade inflammation
US9902996B2 (en) 2011-02-11 2018-02-27 Cedars-Sinai Medical Center Methods of predicting the need for surgery in crohn's disease
ES2762451T3 (es) 2011-04-04 2020-05-25 Berg Llc Tratamiento de tumores del sistema nervioso central con coenzima Q10
AU2013211850B8 (en) * 2012-01-27 2017-06-29 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
EP2647726A1 (de) * 2012-04-05 2013-10-09 Universitätsklinikum Freiburg Kardiovaskuläre Biomarker
JP5963198B2 (ja) 2012-09-26 2016-08-03 国立研究開発法人科学技術振興機構 動的ネットワークバイオマーカーの検出装置、検出方法及び検出プログラム
AU2014241162A1 (en) 2013-03-27 2015-10-22 Cedars-Sinai Medical Center Mitigation and reversal of fibrosis and inflammation by inhibition of TL1A function and related signaling pathways
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
WO2015010108A1 (en) 2013-07-19 2015-01-22 Cedars-Sinai Medical Center Signature of tl1a (tnfsf15) signaling pathway
JP6595478B2 (ja) 2013-09-04 2019-10-23 バーグ エルエルシー コエンザイムｑ１０の連続注入によるがんの治療方法
SG11201800895VA (en) 2015-08-12 2018-03-28 Oncotherapy Science Inc Depdc1-derived peptide and vaccine containing same
CN109462996A (zh) 2016-03-17 2019-03-12 西达-赛奈医疗中心 通过rnaset2诊断炎性肠病的方法
US20180057882A1 (en) * 2016-09-01 2018-03-01 The George Washington University Blood rna biomarkers of coronary artery disease
JP2018005925A (ja) * 2017-08-10 2018-01-11 国立研究開発法人科学技術振興機構 バイオマーカーの候補及び治療用製薬
US11751851B2 (en) * 2021-08-31 2023-09-12 Duke University Methods, systems and computer program products for tissue analysis using ultrasonic backscatter coherence

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352775A (en) * 1991-01-16 1994-10-04 The Johns Hopkins Univ. APC gene and nucleic acid probes derived therefrom
JPH06511387A (ja) * 1991-12-24 1994-12-22 アイシス・ファーマシューティカルス・インコーポレーテッド β−アミロイド調節のための組成物および方法
US5834248A (en) * 1995-02-10 1998-11-10 Millennium Pharmaceuticals Inc. Compositions and methods using rchd534, a gene uregulated by shear stress
US5775329A (en) * 1995-06-07 1998-07-07 Gensia, Inc. Method and compounds for diagnosing coronary artery disease
US5882864A (en) * 1995-07-31 1999-03-16 Urocor Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate disease
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
AU725192B2 (en) * 1996-02-16 2000-10-05 Brigham And Women's Hospital Compositions and methods for the treatment and diagnosis of cardiovascular disease
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US6630301B1 (en) * 1997-03-14 2003-10-07 The Penn State Research Foundation Detection of extracellular tumor-associated nucleic acid in blood plasma or serum
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US6607898B1 (en) * 1996-03-26 2003-08-19 Oncomedx, Inc. Method for detection of hTR and hTERT telomerase-associated RNA in plasma or serum
US5739432A (en) * 1996-05-30 1998-04-14 The Regents Of The University Of California Ultrasonic characterization of single drops of liquids
US6479263B1 (en) * 1996-11-14 2002-11-12 Baylor College Of Medicine Method for detection of micrometastatic prostate cancer
AU722819B2 (en) * 1996-12-06 2000-08-10 Urocor, Inc. Diagnosis of disease state using mRNA profiles
US5830668A (en) * 1996-12-13 1998-11-03 Immunosciences Lab, Inc. Detection of chronic fatigue syndrome
US6190857B1 (en) * 1997-03-24 2001-02-20 Urocor, Inc. Diagnosis of disease state using MRNA profiles in peripheral leukocytes
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US6525185B1 (en) * 1998-05-07 2003-02-25 Affymetrix, Inc. Polymorphisms associated with hypertension
WO2000014232A1 (en) * 1998-09-04 2000-03-16 Trustees Of Tufts College Hypertension associated transcription factor-1 (hatf-1) and hatf related protein 1 (hrp-1)
US6486299B1 (en) * 1998-09-28 2002-11-26 Curagen Corporation Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
US6709855B1 (en) * 1998-12-18 2004-03-23 Scios, Inc. Methods for detection and use of differentially expressed genes in disease states
US6277574B1 (en) * 1999-04-09 2001-08-21 Incyte Genomics, Inc. Genes associated with diseases of the kidney
US6692916B2 (en) * 1999-06-28 2004-02-17 Source Precision Medicine, Inc. Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
WO2001065259A1 (fr) * 2000-03-02 2001-09-07 Genox Research, Inc. Methode d'examen de maladies allergiques
US6974667B2 (en) * 2000-06-14 2005-12-13 Gene Logic, Inc. Gene expression profiles in liver cancer
AU2001276957A1 (en) * 2000-07-17 2002-01-30 Advanced Research And Technology Institute Method of diagnosing pulmonary hypertension
US6602718B1 (en) * 2000-11-08 2003-08-05 Becton, Dickinson And Company Method and device for collecting and stabilizing a biological sample
AU2002241520A1 (en) * 2000-11-28 2003-03-03 University Of Cincinnati Blood assessment of injury
AU2002316251A1 (en) * 2001-06-18 2003-01-02 Rosetta Inpharmatics, Inc. Diagnosis and prognosis of breast cancer patients

Also Published As

Publication number Publication date
EP1643893A2 (de) 2006-04-12
WO2004112589A3 (en) 2008-12-11
US20120165212A1 (en) 2012-06-28
US20050123938A1 (en) 2005-06-09
CA2530191A1 (en) 2004-12-29
EP1643893A4 (de) 2007-12-05
WO2004112589A2 (en) 2004-12-29
JP2007528704A (ja) 2007-10-18
US20070054282A1 (en) 2007-03-08
AU2004249318A1 (en) 2004-12-29
US20130324434A1 (en) 2013-12-05
US20130102484A1 (en) 2013-04-25
US20110065602A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
SG141418A1 (en) Method for the detection of gene transcripts in blood and uses thereof
TW200643175A (en) Markers for prenatal diagnosis and monitoring
WO2005040396A3 (en) qRT-PCR ASSAY SYSTEM FOR GENE EXPRESSION PROFILING
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2007001342A3 (en) Exhaled breath condensate collection and assay system and method
WO2005098445A3 (en) Lung cancer biomarkers
WO2005083440A3 (en) Identification of cancer protein biomarkers using proteomic techniques
ATE548467T1 (de) Verfahren zur identifizierung von biomarkern mit eignung bei der diagnose biologischer zustände
DE60239470D1 (de) Verfahren zur bewertung pathologischer krankheitszustände unter verwendung extrazellulärer rna
WO2004099432A3 (en) Identification of biomarkers for detecting pancreatic cancer
WO2010033371A3 (en) Molecular markers for lung and colorectal carcinomas
WO2009055820A3 (en) Salivary protein biomarkers for human oral cancer
WO2004055519A3 (en) Specific markers for pancreatic cancer
PL2341344T3 (pl) Sposób diagnozowania wielotorbielowatości nerek
WO2005103719A3 (en) Using plasma proteomic pattern for diagnosis, classification, prediction of response to therapy and clinical behavior, stratification of therapy, and monitoring disease in hematologic malignancies
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2008089072A3 (en) Proteomic profiling method useful for condition diagnosis and monitoring, composition screening, and therapeutic monitoring
ATE446385T1 (de) Polymorphismen im nod2/card15 gen
WO2007070560A3 (en) Method for identification and monitoring of epigenetic modifications
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2006059252A3 (en) Methods and fluorinated compositions for treating amyloid-related diseases
WO2006110748A3 (en) Response gene to complement 32 (rgc-32) in disease
EP2074427A4 (de) Diagnostik-biomolekül(e)
WO2003076896A3 (en) Use of biomarkers to detect breast cancer
WO2010051214A8 (en) Compositions and methods for detecting mutations in jak2 nucleic acid